Sort
50,496 grants matching “lung cancer”
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
$542,530Li Li · Case Western Reserve University · U01 · FY2015 · CA
DEVELOPMENTAL FUNDS (Core 002)
$542,437Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$542,407Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Small molecule probes of MYC stability and function intumorigenesis
$542,383Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2024 · CA
TAS:: 75 0872:: TAS LUNG TISSUE RESEACH CONSORTIUM CLINICAL CENTER
$542,181Gerard J Criner · Temple Univ Of The Commonwealth · N01 · FY2014 · HL
Randomized trial of PEITC as a modifier of NNK metabolism in smokers
$542,156Jian-Min Yuan · University Of Minnesota · R01 · FY2012 · CA
A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec
$542,102James F Kronauge · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2012 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$542,097Eric Brouzes · State University New York Stony Brook · R01 · FY2017 · CA
Oncogenic Met Signaling in Urologic Malignancies
$542,075Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Study the role(s) of p53 in embryonic stem cells
$542,071Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Implementation of Smoking Cessation Services within NCI NCORP Community Sites with Organized Lung Cancer Screening Programs
$542,040Kristie L Foley · Wake Forest University Health Sciences · R01 · FY2019 · CA
Personalized Risk Feedback In Dental Clinic Smokers
$542,023Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · DE
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
$542,018Henry Charles Manning · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Multiethnic Genome Scan of Metabolic Phenotypes
$542,011Loic Le Marchand · University Of Minnesota · P01 · FY2013 · CA
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$542,002Donald P McDonnell · Duke University · R01 · FY2025 · CA
Administrative, biospecimen and biostatistical core
$541,994Robert Jenq · Beckman Research Institute/City Of Hope · P01 · FY2024 · HL
Integrated Discovery Pipeline for Tumor Neoantigens
$541,899Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2020 · CA
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$541,884Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2019 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Targeting RET in Lung Cancer
$541,784Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
$541,740Michael D Roth · University Of California Los Angeles · R01 · FY2007 · DA
Analysis of Tumor Dynamics in Progression and Metastasis
$541,731Lewis A Chodosh · University Of Pennsylvania · U01 · FY2007 · CA
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicity
$541,680Donna D Zhang · University Of Arizona · R01 · FY2006 · ES